Evidence map›Paper›PMID 36864660›Full record

ArticleNucleic acids research2023

Human senataxin is a bona fide R-loop resolving enzyme and transcription termination factor.

Zdenka Hasanova, Veronika Klapstova, Odil Porrua, Richard Stefl, Marek Sebesta

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 52 citations in OpenAlex.

  1. Mechanisms and disease relevance of DNA break repair pathway choice.Nature reviews. Molecular cell biology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Outer membrane vesicles fromFrontiers in microbiology · 2026
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Zdenka HasanovaCEITEC-Central European Institute of Technology, Masaryk University, Brno CZ-62500, Czechia.
Veronika KlapstovaCEITEC-Central European Institute of Technology, Masaryk University, Brno CZ-62500, Czechia.
Odil PorruaUniversité Paris Cité, CNRS, Institut Jacques Monod, F-75013 Paris, France.
Richard SteflCEITEC-Central European Institute of Technology, Masaryk University, Brno CZ-62500, Czechia.ORCID 0000-0003-0558-5952
Marek SebestaCEITEC-Central European Institute of Technology, Masaryk University, Brno CZ-62500, Czechia.ORCID 0000-0001-9546-4921
Central European Institute of Technology · CZCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prolonged pausing of the transcription machinery may lead to the formation of three-stranded nucleic acid structures, called R-loops, typically resulting from the annealing of the nascent RNA with the template DNA. Unscheduled persistence of R-loops and RNA polymerases may interfere with transcription itself and other essential processes such as DNA replication and repair. Senataxin (SETX) is a putative helicase, mutated in two neurodegenerative disorders, which has been implicated in the control of R-loop accumulation and in transcription termination. However, understanding the precise role of SETX in these processes has been precluded by the absence of a direct characterisation of SETX biochemical activities. Here, we purify and characterise the helicase domain of SETX in parallel with its yeast orthologue, Sen1. Importantly, we show that SETX is a bona fide helicase with the ability to resolve R-loops. Furthermore, SETX has retained the transcription termination activity of Sen1 but functions in a species-specific manner. Finally, subsequent characterisation of two SETX variants harbouring disease-associated mutations shed light into the effect of such mutations on SETX folding and biochemical properties. Altogether, these results broaden our understanding of SETX function in gene expression and the maintenance of genome integrity and provide clues to elucidate the molecular basis of SETX-associated neurodegenerative diseases.

Indexed as

DNA HelicasesRNA HelicasesTranscription Termination, GeneticGene Expression RegulationHumansMultifunctional EnzymesNeurodegenerative DiseasesR-Loop StructuresSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTranscription FactorsTranscription, GeneticDNA HelicasesMultifunctional EnzymesRNA HelicasesSaccharomyces cerevisiae ProteinsSEN1 protein, S cerevisiaeSETX protein, humanTranscription Factors

Identifiers

PMID36864660
PMCPMC10085699
OpenAlexW4323031957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.